Evidence map›Paper›PMID 42141905›Full record

ArticleHealth policy and planning2026

Participation of civil society organizations and academia in COVID-19 governance: insights from a six country study.

Sumegha Asthana, Roujia Lin, Sanjana Mukherjee, Alexandra L Phelan, Ibrahim B Gobir, J J Woo, Clare Wenham, Mohammad Mushtuq Husain, Tahmina Shirin, Nevashan Govender and 6 more

Abstract read
In one paragraph

Article in Health policy and planning, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Sumegha AsthanaCenter for Global Health Science and Security, Georgetown University, 3900 Reservoir Road NW, Washington, DC, 20057, United States.ORCID 0000-0003-4186-2136
Roujia LinCenter for Global Health Science and Security, Georgetown University, 3900 Reservoir Road NW, Washington, DC, 20057, United States.
Sanjana MukherjeeO'Neill Institute for National and Global Health Law, Georgetown University, 600 New Jersey Avenue NW, Washington, DC, 2001, United States.
Alexandra L PhelanDepartment of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, 615 N Wolfe St, Baltimore, MD, 21205, United States.
Ibrahim B GobirGeorgetown Global Health LTD/GTE Nigeria, No. 2 Babatope Ajakaiye Crescent, Jahi District, Gwarinpa, Abuja, 900108, Nigeria.ORCID 0000-0002-3640-7772
J J WooLee Kuan Yew School of Public Policy, National University of Singapore, 469C Bukit Timah Road, Singapore, 259772, Singapore.
Clare WenhamDepartment of Health Policy, London School of Economics and Political Science, Houghton Street, London, WC2A 2AE, United Kingdom.ORCID 0000-0001-5378-3203
Mohammad Mushtuq HusainInstitute of Epidemiology, Disease Control and Research (IEDCR), 44 Mohakhali, Dhaka 1212, Bangladesh.
Tahmina ShirinInstitute of Epidemiology, Disease Control and Research, 44 Mohakhali, Dhaka, 1212, Bangladesh.ORCID 0000-0002-5061-3783
Nevashan GovenderNational Institute for Communicable Diseases, 1 Modderfontien Road, Sandringham, Johannesburg, 2131, South Africa.
Mohannad Al NsourEastern Mediterranean Public Health Network, Abdallah Ben Abbas St, Building No. 42, Amman, 11196, Jordan.
Winifred UkponuGeorgetown Global Health LTD/GTE Nigeria, No. 2 Babatope Ajakaiye Crescent, Jahi District, Gwarinpa, Abuja, 900108, Nigeria.
Adachioma C IhuezeIndependent Consultant, Ontario, Canada.
Sumit AsthanaIndependent Consultant, Washington, DC, 20007, United States.
Renee Vongai MutareCenter for Global Health Science and Security, Georgetown University, 3900 Reservoir Road NW, Washington, DC, 20057, United States.
Claire J StandleyCenter for Global Health Science and Security, Georgetown University, 3900 Reservoir Road NW, Washington, DC, 20057, United States.ORCID 0000-0002-4291-9723

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This paper focuses on the engagement of persons and groups with diverse interests in the governance of the COVID-19 pandemic. During emergencies, involving diverse perspectives in governance mechanisms can contribute to more equitable and evidence-based policies that address societal needs. Previous literature shows that, even with the intent to include diverse perspectives, there can be gaps in engaging non-governmental entities in epidemic governance. This study sought to analyze participation of two important interest groups: academia and civil society organizations (CSOs) during the COVID-19 response, to identify best practices and strategies for enhancing their roles in future health crisis governance. We adopted a comparative case study design to collect data from six countries: Nigeria, Singapore, South Africa, Bangladesh, Jordan, and the United Kingdom, representing varied political and economic contexts, geographic locations, and response strategies during the pandemic. Data sources included key informant interviews and focus group discussions with a total of 64 stakeholders, including government officials, academic experts, and personnel from CSOs. During the COVID-19 pandemic, CSOs actively participated in response efforts, but in the six countries we analyzed, they largely did so independently of the government, particularly during the initial response phase. In some countries, governments involved CSOs only after reports of clusters of new transmission, primarily for risk communication and service delivery like vaccine distribution, without involving them in governance mechanisms like making pandemic preparedness and response policies. Other governments worked with public universities to gather evidence for decision-making and policy formulation starting from the pre-pandemic phase to the initial phase of the pandemic. Across disciplines, experts in epidemiology, mathematical modelling, and infectious diseases were more likely to be consulted, whereas economists, sociologists, ethicists, and anthropologists were less involved.

Indexed as

COVID-19PandemicsAcademiaFocus GroupsHealth PolicyHumansNigeriaSARS-CoV-2SingaporeSocial GroupSouth AfricaUnited Kingdomacademiacivil societyCOVID-19decision-makinghealth emergenciesinclusive governancemulti-sectoral governance

Identifiers

PMID42141905
PMCPMC13481672

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.